Acadia Pharmaceuticals ACAD Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's short-term investments?
- Acadia Pharmaceuticals (ACAD) reported short-term investments of $569.25M in Q1 2026.
- How has Acadia Pharmaceuticals's short-term investments changed year-over-year?
- Acadia Pharmaceuticals's short-term investments increased by 22.7% year-over-year, from $463.88M to $569.25M.
- What is the long-term trend for Acadia Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's short-term investments has grown at a 16.0% compound annual growth rate (CAGR), from $305.93M to $641.99M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.